Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin B12Vitamin B12 (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Association between low serum folic acid and vitamin B12 levels with COVID-19 prognosis

Keskin et al., Progress in Nutrition, doi:10.23751/pn.v24i3.13462
Sep 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Hospitalization time -3% Improvement Relative Risk Vitamin B12 for COVID-19  Keskin et al.  Sufficiency Are vitamin B12 levels associated with COVID-19 outcomes? Retrospective 264 patients in Turkey (April 2019 - October 2021) No significant difference in hospitalization c19early.org Keskin et al., Progress in Nutrition, Sep 2022 Favorsvitamin B12 Favorscontrol 0 0.5 1 1.5 2+
34th treatment shown to reduce risk in February 2022, now with p = 0.023 from 4 studies.
Lower risk for recovery.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Retrospective 529 hospitalized COVID-19 patients in Turkey showing lower serum folic acid levels associated with longer hospitalization and higher mortality. Folic acid deficiency and insufficiency were common. There was no significant association for vitamin B12 levels and outcomes. Authors hypothesize that folic acid may support the immune response against SARS-CoV-2 and reduce inflammation.
Study covers vitamin B9 and vitamin B12.
hospitalization time, 3.0% higher, relative time 1.03, p = 0.70, treatment mean 10.2 (±5.8) n=132, control mean 9.9 (±6.64) n=132.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Keskin et al., 27 Sep 2022, retrospective, Turkey, peer-reviewed, mean age 62.8, 3 authors, study period April 2019 - October 2021.
This PaperVitamin B12All
Association Between Low Serum Folic Acid and Vitamin B 12 Levels with Covid-19 Prognosis
MD Olgun Keskin, Ayşegül Seremet Keskin, Nilgün Seremet Kürklü
doi:10.23751/pn.v24i3.13462
Background and aim: It is important that the immune system is active and strong in protection from the COVID-19 pandemic. Folic acid and vitamin B 12 are involved in the initiation, maintenance and regulation of both innate and adaptive immune reactions of the host against infections. In this study, it was aimed to investigate the relationship between serum folic acid and vitamin B 12 levels of COVID-19 patients on the prognosis of the disease. Methods: The sample of the study consists of 529 individuals hospitalized in the Pandemic Chest Diseases Intensive Care Unit. General characteristics of the individuals, biochemical parameters checked routinely (white blood cell (WBC), platelet (PLT), lymphocyte, Neutrophil/Lymphocyte (N/L) rate, C-reactive protein (CRP), oxygen (O 2 ) saturation at the time of admission), serum vitamin B 12 and folic acid levels, length of stay in intensive care units (ICUs) and hospitalization, and mortality were recorded. Results: The mean age of individuals was 62.8±15.12 years, and 50.9% were men and 49.1% were women. The mean level of serum folic acid in the subjects was 9.1±4.91 (ng/mL), and 2.4% had folic acid deficiency and 28.4% had folic acid insufficiency. The mean serum vitamin B 12 was 295.6±229.98 (pg/mL), and vitamin B 12 deficiency was observed only in 14.4%. The increase in serum folic acid levels reduces the total length of hospitalization and the risk of mortality (p<0.05). On the other hand, no correlation was found between B 12 levels and the length of stay in ICU, hospitalization, and mortality. It was shown that WBC and N/L rates decreased as serum folic acid levels increased, and O 2 saturation at the first hospital admission was higher. Conclusions: Folate deficiency and insufficiency are common among hospitalized COVID-19 patients and cause progression to severe disease. Therefore, examining COVID-19 patients in terms of nutritional deficiencies is critical in monitoring the clinical outcomes of the disease.
Conflict of Interest: All authors declare no conflict of interest related to this study.
References
Acosta-Elias, Espinosa-Tanguma, The folate concentration and/or folic acid metabolites in plasma as factor for COVID-19 infection, Front Pharmacol
Calder, Nutrition, immunity and COVID-19, BMJ Nutr Prev Health
Dalbeni, Bevilacqua, Teani, Normelli, Mazzaferri et al., Excessive vitamin B12 and poor outcome in COVID-19 pneumonia, Nutr Metab Cardiovasc Dis
Ersöz, Yılmaz, The association between micronutrient and hemogram values and prognostic factors in COVID-19 patients: A single-center experience from Turkey, Int J Clin Pract
Fedele, Francesco, Riso, Collo, Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview, Nutr
Gasmi, Tippairote, Mujawdiya, Micronutrients as immunomodulatory tools for COVID-19 management, Clin Immunol
Hu, Huang, Yin, The cytokine storm and COVID-19, J Med Virol
Ibrahimagić, Kunić, Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia, Med Hypotheses
Iddir, Brito, Dingeo, Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis, Nutrients
Itelman, Wasserstrum, Segev, Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center, Isr Med Assoc J
Jayawardena, Sooriyaarachchi, Chourdakis, Jeewandara, Ranasinghe et al., Enhancing immunity in viral infections, with special emphasis on COVID-19: A review, Diabetes Metab Syndr
Kumar, Kancharla, Jena, In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19, Virusdisease
Kürklü, Keskin, Türker, Is High Body Mass Index a Risk Factor for COVID-19?, Bezmialem Sci
Meisel, Efros, Bleier, Folate levels in patients hospitalized with coronavirus disease 2019, Nutrients
Serseg, Benarous, Yousfi, Hispidin and Lepidine E: two Natural Compounds and Folic acid as Potential Inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study, Curr. Comput.-Aided Drug Des
Shakeri, Azimian, Ghasemzadeh-Moghaddam, Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19, J Med Virol
Shakoor, Feehan, Mikkelsen, Be well: A potential role for vitamin B in COVID-19, Maturitas
Sheybani, Dokoohaki, Negahdaripour, The role of folic acid in the management of respiratory disease caused by COVID-19
Siordia, Epidemiology and clinical features of COVID-19: A review of current literature, J Clin Virol
Spence, Yi, Hankey, B vitamins in stroke prevention: time to reconsider, Lancet Neurol
Taheri, Bahrami, Habibi, Nouri, A review on the serum electrolytes and trace elements role in the pathophysiology of COVID-19, Biol Trace Elem Res
Tek, Koçak, Koronavirüsle (Covid-19) Mücadelede Beslenmenin Bağişiklik Sisteminin Desteklenmesinde Rolü. Gazi Sağlık Bil Derg, Özel Sayı
Wee, COVID-19's toll on the elderly and those with diabetes mellitus-is vitamin B12 deficiency an accomplice?, Med Hypotheses
Wiltshire, Peña, Mackenzie, Shaw, Couper, High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia, Med Hypotheses
Şenyiğit, COVID-19 Pandemisi. Klinik, Tanı, Tedavi ve Korunma, Dicle Tip Derg
{ 'type': 'article-journal', 'language': 'eng', 'author': [ {'family': 'Keskin', 'given': 'Olgun'}, {'family': 'Seremet Keskin', 'given': 'Ayşegül'}, {'family': 'Nilgün Seremet', 'given': 'Nilgün Seremet'}], 'issued': {'date-parts': [[2022, 9, 27]]}, 'abstract': 'Background and aim: It is important that the immune system is active and strong in protection ' 'from the COVID-19 pandemic. Folic acid and vitamin B12 involved in the initiation, ' 'maintenance and regulation of both innate and adaptive immune reactions of the host against ' 'the infections. In this study, it was aimed to investigate the relationship between serum ' 'folic acid and vitamin B12 levels of COVID-19 patients on the prognosis of the disease. ' 'Methods: The sample of the study consists of 529 individuals hospitalized in the Pandemic ' 'Chest Diseases Intensive Care Unit. General characteristics of the individuals, biochemical ' 'parameters checked routinely (white blood cell (WBC), platelet (PLT), lymphocyte, ' 'Neutrophil/Lymphocyte (N/L) rate, C-reactive protein (CRP), oxygen (O2) saturation at the ' 'time of admission), serum vitamin B12 and folic acid levels, length of stay in intensive care ' 'unit (ICU) and hospitalization, and mortality were recorded. \xa0 Results: The mean age of ' 'individuals was 62.8±15.12 years, and 50.9% were men and 49.1% women. The mean level of serum ' 'folic acid in the subjects was 9.1±4.91 (ng/mL), and 2.4% had folic acid deficiency and 28.4% ' 'had folic acid insufficiency. The mean serum vitamin B12 was 295.6±229.98 (pg/mL), and ' 'vitamin B12 deficiency was observed only in 14.4%. The increase in serum folic acid levels ' 'reduces the total length of hospitalization and the risk of mortality (p<0.05). On the other ' 'hand, no correlation was found between B12 levels and the length of stay in ICU, ' 'hospitalization and mortality. It was shown that WBC and N/L rate decreased as serum folic ' 'acid levels increased, and O2 saturation at the first hospital admission was higher. ' 'Conclusions: Folate deficiency and insufficiency are common among hospitalized COVID-19 ' 'patients and cause progression to severe disease. Therefore, examining COVID-19 patients in ' 'terms of nutritional deficiencies is critical in monitoring the clinical outcomes of\xa0 ' 'disease', 'container-title': 'Progress in Nutrition', 'DOI': '10.23751/pn.v24i3.13462', 'ISSN': '1129-8723', 'issue': '3', 'medium': 'JB', 'page': 'e2022104', 'page-first': 'e2022104', 'publisher': 'Mattioli 1885', 'publisher-place': 'IT', 'title': 'Association between low serum folic acid and vitamin B12 levels with COVID-19 prognosis', 'URL': 'https://doi.org/10.23751/pn.v24i3.13462', 'volume': '24'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit